Eagle Pharmaceuticals to Present at 21st Annual NewsMakers in the Biotechnology Industry Investment Conference

Tuesday, September 23, 2014 10:41 am EDT

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX
US2697961082

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, will present at the 21st Annual BioCentury NewsMakers Conference as follows:

      Date:     Friday, September 26, 2014
Time: 2:30 p.m. EDT
Venue: Millennium Broadway Hotel and Conference Center, New York City.
 

A live audio webcast of the presentation will be available under the investor relations section of Eagle's website at http://investor.eagleus.com/events-calendar. A replay of the presentation will be available for 60 days following the event.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. The Company’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

Contact:

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Business Wire InvestorHQsm